These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Assessment of fatigue in the management of patients with ankylosing spondylitis. Dernis-Labous E; Messow M; Dougados M Rheumatology (Oxford); 2003 Dec; 42(12):1523-8. PubMed ID: 13130145 [TBL] [Abstract][Full Text] [Related]
3. The effect of balneotherapy on patients with ankylosing spondylitis. Altan L; Bingöl U; Aslan M; Yurtkuran M Scand J Rheumatol; 2006; 35(4):283-9. PubMed ID: 16882592 [TBL] [Abstract][Full Text] [Related]
4. Self- and manual mobilization improves spine mobility in men with ankylosing spondylitis--a randomized study. Widberg K; Karimi H; Hafström I Clin Rehabil; 2009 Jul; 23(7):599-608. PubMed ID: 19403551 [TBL] [Abstract][Full Text] [Related]
5. Clinimetric evaluation of the bath ankylosing spondylitis metrology index in a controlled trial of pamidronate therapy. Jauregui E; Conner-Spady B; Russell AS; Maksymowych WP J Rheumatol; 2004 Dec; 31(12):2422-8. PubMed ID: 15570645 [TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of infliximab in patients with ankylosing spondylitis: results of a randomized, placebo-controlled trial (ASSERT). van der Heijde D; Dijkmans B; Geusens P; Sieper J; DeWoody K; Williamson P; Braun J; Arthritis Rheum; 2005 Feb; 52(2):582-91. PubMed ID: 15692973 [TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of mesalazine (Salofalk) in an open study of 20 patients with ankylosing spondylitis. van Denderen JC; van der Horst-Bruinsma I; Bezemer PD; Dijkmans BA J Rheumatol; 2003 Jul; 30(7):1558-60. PubMed ID: 12858458 [TBL] [Abstract][Full Text] [Related]
8. Therapeutic efficacy and safety of multiple intravenous infusions of infliximab in refractory ankylosing spondylitis patients with axial involvement. Rejón E; Giménez MD; Mayordomo L; Rodríguez S; González MP; Marenco JL Scand J Rheumatol; 2004; 33(5):323-6. PubMed ID: 15513681 [TBL] [Abstract][Full Text] [Related]
9. A comparative study of benoxaprofen and ketoprofen in ankylosing spondylitis. Charlot J; Villiaumey J Eur J Rheumatol Inflamm; 1982; 5(2):277-81. PubMed ID: 7044803 [TBL] [Abstract][Full Text] [Related]
10. Proquazone (Biarison) and indomethacin (Indocid) in the treatment of ankylosing spondylitis. Two comparative, clinical, double-blind studies. Nissilä M; Kajander A Scand J Rheumatol Suppl; 1978; (21):36-9. PubMed ID: 356241 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of methotrexate in ankylosing spondylitis: a randomized, double blind, placebo controlled trial. Gonzalez-Lopez L; Garcia-Gonzalez A; Vazquez-Del-Mercado M; Muñoz-Valle JF; Gamez-Nava JI J Rheumatol; 2004 Aug; 31(8):1568-74. PubMed ID: 15290737 [TBL] [Abstract][Full Text] [Related]
12. Six-month results of a double-blind, placebo-controlled trial of etanercept treatment in patients with active ankylosing spondylitis. Brandt J; Khariouzov A; Listing J; Haibel H; Sörensen H; Grassnickel L; Rudwaleit M; Sieper J; Braun J Arthritis Rheum; 2003 Jun; 48(6):1667-75. PubMed ID: 12794835 [TBL] [Abstract][Full Text] [Related]
13. Stability of the patient acceptable symptomatic state over time in outcome criteria in ankylosing spondylitis. Tubach F; Pham T; Skomsvoll JF; Mikkelsen K; Bjørneboe O; Ravaud P; Dougados M; Kvien TK Arthritis Rheum; 2006 Dec; 55(6):960-3. PubMed ID: 17139643 [TBL] [Abstract][Full Text] [Related]
14. Baseline factors that influence ASAS 20 response in patients with ankylosing spondylitis treated with etanercept. Davis JC; Van der Heijde DM; Dougados M; Braun J; Cush JJ; Clegg DO; Inman RD; de Vries T; Tsuji WH J Rheumatol; 2005 Sep; 32(9):1751-4. PubMed ID: 16142873 [TBL] [Abstract][Full Text] [Related]
15. [Clinical study of etanercept for treating ankylosing spondylitis]. Liang LQ; Zhan ZP; Ye YJ; Fu D; Xu HS; Yang XY Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug; 28(8):1349-51. PubMed ID: 18753057 [TBL] [Abstract][Full Text] [Related]
16. Persistent clinical response to the anti-TNF-alpha antibody infliximab in patients with ankylosing spondylitis over 3 years. Braun J; Baraliakos X; Brandt J; Listing J; Zink A; Alten R; Burmester G; Gromnica-Ihle E; Kellner H; Schneider M; Sörensen H; Zeidler H; Sieper J Rheumatology (Oxford); 2005 May; 44(5):670-6. PubMed ID: 15757965 [TBL] [Abstract][Full Text] [Related]
17. [Effect and tolerance of Biarison (proquazone) in rheumatoid arthritis (author's transl)]. Ghimicescu R MMW Munch Med Wochenschr; 1978 Jun; 120(26):901-4. PubMed ID: 307165 [TBL] [Abstract][Full Text] [Related]
18. [Clinical features of ankylosing spondylitis--epidemiologic study]. Jajić Z; Grazio S; Nemcić T; Jajić I Reumatizam; 1997; 45(2):13-8. PubMed ID: 9769723 [TBL] [Abstract][Full Text] [Related]
19. Etanercept exerts beneficial effects on articular cartilage biomarkers of degradation and turnover in patients with ankylosing spondylitis. Maksymowych WP; Poole AR; Hiebert L; Webb A; Ionescu M; Lobanok T; King L; Davis JC J Rheumatol; 2005 Oct; 32(10):1911-7. PubMed ID: 16206346 [TBL] [Abstract][Full Text] [Related]
20. Outcome of patients with active ankylosing spondylitis after two years of therapy with etanercept: clinical and magnetic resonance imaging data. Baraliakos X; Brandt J; Listing J; Haibel H; Sörensen H; Rudwaleit M; Sieper J; Braun J Arthritis Rheum; 2005 Dec; 53(6):856-63. PubMed ID: 16342093 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]